KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial

KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial

Bibliographic Details
Main Authors:	West, N, Hemmings, G, Richman, S, Taylor, M, Chambers, P, Magill, L, Lancaster, D, Taniere, P, Handley, K, Brown, G, Ferry, D, Seymour, M, Gray, R, Morton, D, Warren, B, Quirke, P
Format:	Conference item
Published:	2012

Similar Items

Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial
by: West, N, et al.
Published: (2012)

FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer
by: Gray, R, et al.
Published: (2010)

FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report
by: Morton, D, et al.
Published: (2011)

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy
by: Yoshiaki Amino, et al.
Published: (2023-11-01)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
by: Ming Li, et al.
Published: (2021-01-01)

Biopsy! Biopsy! Biopsy!
by: Ramin Shayan
Published: (2019-10-01)

Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies
by: Jean Yin Tan, et al.
Published: (2021-02-01)

ANALYSIS OF MUTATIONS IN KRAS AND BRAF GENES IN COLORECTAL CANCER IN RUSSIAN PATIENTS
by: E. E. Pisareva, et al.
Published: (2016-07-01)

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
by: Adams, R, et al.
Published: (2017)

The effect of the term of mulching and herbicides spraying on ‘Foxtrot’ tulip flowering and bulbs yield
by: Barbara Marcinek, et al.
Published: (2019-08-01)

KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
by: Rita Chiari, et al.
Published: (2023-11-01)

The prevalence of KRAS and BRAF mutation in colorectal cancer patients in Bali
by: Ayu Dewi Ni Nyoman, et al.
Published: (2022-03-01)

Biopsy Procedure and Preparation (Including Biopsy Medium and Biopsy Dish)
by: Tiencheng Arthur Chang
Published: (2023-12-01)

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials
by: Seligmann, JF, et al.
Published: (2016)

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
by: Lafarge, MW, et al.
Published: (2024)

Panties, Hearts and Foxtrots: Translations of Popular Songs within the Croatian Record Industry in the Interwar Period
by: Jelka Vukobratović
Published: (2022-01-01)

FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS and NRAS
by: Adams, R, et al.
Published: (2016)

PIK3CA Mutation is Strongly Associated with K-ras 12/13 Mutation in Stage II/III Colorectal Cancer
by: Southward, K, et al.
Published: (2012)

Re-Biopsy and Biopsy of Post-vitrified Blastocyst
by: Krishna Mantravadi
Published: (2023-12-01)

Prostate Biopsy: General Consideration and Systematic Biopsy
by: Hyungwoo Ahn
Published: (2023-11-01)

Canines globe-trot in a day
by: Lim, Jarod
Published: (2018)

Differences in pain perception during open muscle biopsy and Bergstroem needle muscle biopsy
by: Dengler J, et al.
Published: (2014-11-01)

Antegrade Endobiliary Forceps Biopsy Improves Diagnosis of Klatskin Tumor Compared to Brush Biopsy
by: A. V. Kozlov, et al.
Published: (2022-08-01)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
by: İvo Gökmen, et al.
Published: (2023-09-01)

KRAS and BRAF Concomitant Mutations in a Patient with Metastatic Colon Adenocarcinoma: An Interesting Case Report
by: Concetta Cafiero, et al.
Published: (2020-06-01)

Transjugular liver biopsy
by: Antonio C. Maciel, et al.
Published: (2022-07-01)

Comparison of Immunohistochemical Markers in Core Needle Biopsy and Excisional Biopsy in Breast Carcinoma
by: ALFATIH P.,, et al.
Published: (2015)

<i>BRAF</i> V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors
by: Noemi García-Romero, et al.
Published: (2019-12-01)

Liquid Biopsy in Glioblastoma
by: Lorian Ronvaux, et al.
Published: (2022-07-01)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
by: Grzegorz Rempega, et al.
Published: (2023-02-01)

NCRI CTRad workshop: translating novel discoveries to and from the clinic
by: Hak, CCW, et al.
Published: (2023)

Kaposiform Hemangioendothelioma of the pancreas requiring biopsy for diagnosis
by: Jasmine D. Lee, et al.
Published: (2023-01-01)

High resolution melting analysis for rapid and sensitive <it>EGFR </it>and <it>KRAS </it>mutation detection in formalin fixed paraffin embedded biopsies
by: Fox Stephen B, et al.
Published: (2008-05-01)

Renal Biopsy
by: Taek Min Kim, et al.
Published: (2023-11-01)

High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
by: Heriyanto, Didik Setyo, et al.
Published: (2022)

High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
by: Didik Setyo Heriyanto, et al.
Published: (2022-12-01)

High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE‐hypermutated colorectal cancers
by: Loetitia Favre, et al.
Published: (2022-09-01)

The Role of Saturation Transperineal Biopsy in the Diagnosis of Prostate Cancer in the Era of Targeted Fusion Biopsies
by: A. A. Keln, et al.
Published: (2018-10-01)

Biopsying Diabetics … How Risky Is It?
by: Jonathan J. Taliercio, et al.
Published: (2022-02-01)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
by: Wojciech Malewski, et al.
Published: (2023-08-01)